MoneyWorks4Me

Jenburkt Pharmaceuticals informs about annual disclosure

14 Apr 2026 Evaluate
Pursuant to SEBI Circular SEBI/HO/DDHS/CIR/2021/613 dated 10th August, 2021 (updated on 13th April, 2022 by SEBI), Jenburkt Pharmaceuticals has confirmed that for the financial year ended on 31st March, 2026, the company is ‘not a large corporate’ as per the applicability criteria mentioned in Clause 2.1 of Chapter XII therein.

The above information is a part of company’s filings submitted to BSE. 
Peers
Company Name CMP
Sun Pharma. Inds. 1820.00
Dr. Reddys Labs. 1236.00
Cipla 1350.00
Lupin 2042.00
Zydus Lifesciences 1163.35
View more..